» Articles » PMID: 32664929

Nasal Microbiota Dominated by Moraxella Spp. is Associated with Respiratory Health in the Elderly Population: a Case Control Study

Overview
Journal Respir Res
Specialty Pulmonary Medicine
Date 2020 Jul 16
PMID 32664929
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The elderly (≥65 years) are one of the populations most at risk for respiratory tract infections (RTIs). The aim of this study was to determine whether nasal and/or oropharyngeal microbiota profiles are associated with age and RTIs.

Methods: Nasal and oropharyngeal swabs of 152 controls and 152 patients with an RTI were included. The latter group consisted of 72 patients with an upper respiratory tract infection (URTI) and 80 with a lower respiratory tract infection (LRTI). Both nasal and oropharyngeal swabs were subjected to microbiota profiling using amplicon sequencing of the 16S rRNA gene. Moraxella species were determined using quantitative real-time PCR and culture.

Results: Based on the microbiota profiles of the controls and the patients with an RTI, eight nasal and nine oropharyngeal microbiota clusters were defined. Nasal microbiota dominated by either Moraxella catarrhalis or Moraxella nonliquefaciens was significantly more prevalent in elderly compared to mid-aged adults in the control group (p = 0.002). Dominance by M. catarrhalis/nonliquefaciens was significantly less prevalent in elderly with an LRTI (p = 0.001) compared to controls with similar age.

Conclusions: Nasal microbiota dominated by M. catarrhalis/nonliquefaciens is associated with respiratory health in the elderly population.

Citing Articles

Oropharyngeal microbiome profiling and its association with age and heart failure in the elderly population from the northernmost province of China.

Liu J, He X, Yang K, Zhao Y, Dai E, Chen W Microbiol Spectr. 2024; 12(10):e0021624.

PMID: 39162522 PMC: 11448084. DOI: 10.1128/spectrum.00216-24.


Meta-analysis of the human upper respiratory tract microbiome reveals robust taxonomic associations with health and disease.

Quinn-Bohmann N, Freixas-Coutin J, Seo J, Simmons R, Diener C, Gibbons S BMC Biol. 2024; 22(1):93.

PMID: 38654335 PMC: 11040984. DOI: 10.1186/s12915-024-01887-0.


Association between Moraxella keratitis and advanced glycation end products.

Inoue H, Toriyama K, Takahira N, Murakami S, Miyamoto H, Suzuki T Sci Rep. 2024; 14(1):8024.

PMID: 38580798 PMC: 10997605. DOI: 10.1038/s41598-024-58659-7.


Winds of change a tale of: asthma and microbiome.

Galeana-Cadena D, Gomez-Garcia I, Lopez-Salinas K, Irineo-Moreno V, Jimenez-Juarez F, Tapia-Garcia A Front Microbiol. 2023; 14:1295215.

PMID: 38146448 PMC: 10749662. DOI: 10.3389/fmicb.2023.1295215.


The upper respiratory tract microbiota of healthy adults is affected by Streptococcus pneumoniae carriage, smoking habits, and contact with children.

Paulo A, Lanca J, Almeida S, Hilty M, Sa-Leao R Microbiome. 2023; 11(1):199.

PMID: 37658443 PMC: 10474643. DOI: 10.1186/s40168-023-01640-9.


References
1.
. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018; 392(10159):1736-1788. PMC: 6227606. DOI: 10.1016/S0140-6736(18)32203-7. View

2.
Unger S, Bogaert D . The respiratory microbiome and respiratory infections. J Infect. 2017; 74 Suppl 1:S84-S88. DOI: 10.1016/S0163-4453(17)30196-2. View

3.
van den Munckhof E, de Koning M, Quint W, van Doorn L, Leverstein-van Hall M . Evaluation of a stepwise approach using microbiota analysis, species-specific qPCRs and culture for the diagnosis of lower respiratory tract infections. Eur J Clin Microbiol Infect Dis. 2019; 38(4):747-754. DOI: 10.1007/s10096-019-03511-4. View

4.
de Steenhuijsen Piters W, Heinonen S, Hasrat R, Bunsow E, Smith B, Suarez-Arrabal M . Nasopharyngeal Microbiota, Host Transcriptome, and Disease Severity in Children with Respiratory Syncytial Virus Infection. Am J Respir Crit Care Med. 2016; 194(9):1104-1115. PMC: 5114450. DOI: 10.1164/rccm.201602-0220OC. View

5.
Pereira P, Aho V, Paulin L, Pekkonen E, Auvinen P, Scheperjans F . Oral and nasal microbiota in Parkinson's disease. Parkinsonism Relat Disord. 2017; 38:61-67. DOI: 10.1016/j.parkreldis.2017.02.026. View